VANCOUVER B.C.: July 8th, 2019 – EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC) (“Empower” or the “Company”), a vertically integrated and growth-oriented CBD life sciences company, and a multi-state operator of medical health & wellness clinics, is pleased to announce that the Company’s clinic division, Sun Valley Health, has completed it’s 2019 Franchise Disclosure Document (FDD) and has commenced selling Sun Valley Health franchises in the United States. Learn more at http://www.sunvalleyhealth.com
With the completion of the 2019 Franchise Disclosure Document (FDD) the Company is now selling Sun Valley Health franchises and is accepting franchise applications effectively immediately.
The Company has invested in the development of a new franchise trade show booth that showcases the Sun Valley Health opportunity to perspective franchisees using dynamic, content rich displays and four (4) large format television monitors to present features and benefits to the audience who attend the expos.
The franchise sales teams are booked to participate in the International Franchise Expo https://www.ifeinfo.com and the Cannabis Industry Marketplace Expo www.cannabisimp.com with nine (9) expos booked to showcase the Sun Valley Health franchise opportunity.
Missouri July 23-24th 2019 (Cannabis Expo)
Chicago Sept. 13th-14th 2019 (Franchise Expo)
Chicago Sept. 19th-20th 2019 (Cannabis Expo)
Houston Oct. 4th-5th 2019 (Franchise Expo)
Florida Nov. 13th-14th 2019 (Cannabis Expo)
Long Beach Dec. 5th-6th 2019 (Franchise Expo)
Arizona Feb. 12th-13th 2020 (Cannabis Expo)
Miami Feb. 20th-22nd 2019 (Franchise Expo)
Michigan April: 15th-17th 2020 (Cannabis Expo)
“Offering our years of experience in operating clinics to potential franchise partners across America is an exceptional growth opportunity for our Company, said Steven McAuley, CEO of Empower Clinics Inc. “We have the opportunity to connect to exponentially more patients who can benefit from direct access to physicians that provide consultations on alternative treatment options.”
The upcoming expos are expected to generate significant interest in the Sun Valley Health brand and it will allow the Company’s franchise sales teams to communicate the benefits and opportunities the industry can offer entrepreneurs, medical professionals and consumers in general.
The Company clinics offer consultations on the potential benefits of CBD based treatment options to address a variety of qualifying conditions including chronic pain, anxiety, PTSD, insomnia, indigestion and other serious aliments that can affect the lives of so many people. The Company also has commenced building retail product kiosks in all clinics offering more than 40 products SKU’s that patients can purchase in-clinic or online. All Sun Valley Health franchises will include similar retail product kiosks that offer Sun Valley Health approved products options.
“Our scientific approach to alternative medicine offers franchisees & patients across America access to quality CBD, MMJ cards, nutritional supplements, and holistic modalities with Physicians and medical professionals on hand and available in our clinics.” said Dustin Klein, Empowers SVP, Business Development and Director.
Each Company owned clinic and all franchised clinics in our nationwide network will offer a full range of CBD products and health & wellness supplements, that provide a wide array of choices to patients and customers in the communities we serve.
Empower is a leading multi-state operator of a network of physician-staffed clinics focused on helping patients improve and protect their health through innovative physician recommended treatment options. Operating as a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company can produce and package its proprietary line of cannabidiol (CBD) based products and distribute through company owned and franchised clinics, with wholesale partnerships, online and with retailers nationwide.
ON BEHALF OF THE BOARD OF DIRECTORS:
Chief Executive Officer
Investors: Steve Low
Boom Capital Markets
For French inquiries: Remy Scalabrini, Maricom Inc., E: firstname.lastname@example.org, T: (888) 585-MARI
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the terms of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; access to Empower’s home delivery and e-commerce platform; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that the hemp-based CBD extraction facility may not be fully operation by Q2 2019 if at all; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.